Steve E. Krognes, CFO and Treasurer at Denali Therapeutics Inc. (DNLI), sold 5,670 shares at $70.17 ($398K) on 2021-02-11, disclosed to the SEC on 2021-02-16.
Open-market sale of $398k DNLI by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.17 | 2,635 | $185K | 46.4% |
| 2 | $70.17 | 2,635 | $185K | 46.4% |
| 3 | $71.43 | 400 | $29K | 7.2% |
| Total | $70.26 avg | 5,670 | $398K | 100% |
| Filing → |
| DNLI | SELL | 2025-01-08 | $139K | — | Filing → |
| DNLI | SELL | 2025-01-03 | $608K | — | Filing → |
| DNLI | SELL | 2024-10-02 | $871K | — | Filing → |